The Benefit Of A “Light Touch” In Identifying Melanoma In Natalizumab Treated Patients- A Southern Network On Adverse Reactions (Sonar) Analysis Based On The Tysabri Outreach Commitment To Health Registry (Touch)
Abstract
Authors
V Noxon O Sartor P Yarnold CL Bennett DW Raisch